🇺🇸 FDA
Patent

US 11130740

Substituted 2,3-dihydro-1H-indene analogs and methods using same

granted A61KA61K45/06A61P

Quick answer

US patent 11130740 (Substituted 2,3-dihydro-1H-indene analogs and methods using same) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K45/06, A61P, A61P31/20